Janssen Covid vaccine deliveries to Europe on hold over new blood clot study
3 years, 8 months ago

Janssen Covid vaccine deliveries to Europe on hold over new blood clot study

NL Times  

Deliveries of the Johnson & Johnson vaccine against Covid-19 to the European Economic Area, including the Netherlands, will be delayed as part of a new review of data to determine if the vaccine is linked to six blood clot cases in the United States. "We are aware of an extremely rare disorder involving people with blood clots in combination with low platelets in a small number of individuals who have received our COVID-19 vaccine," the parent company said in a statement issued on Tuesday. The vaccine, approved in Europe for use on March 11, only requires one shot to offer maximum protection against Covid-19, whereas the other three vaccines used in the Netherlands require two doses. So far, 6.8 million people have received the Janssen vaccine, with six reports of a the rare blood clot side effect in women aged 18 to 48. In response to the first reports of blood clots combined with low platelet counts, the European Medicines Agency's safety committee PRAC said last week that it was closely monitoring all reported side effects linked to the Janssen vaccine.

Europe Netherlands Vaccine Janssen  hold  deliveries  reports  netherlands  europe  study  covid  covid19  janssen  women  clot  safety  review  vaccine  european  blood

History of this topic

Covishield Side Effects: Doctors' Group Urges Govt to Review All Covid Vaccines
7 months, 2 weeks ago

Covishield Side Effects: Doctors' Group Urges Govt to Review All Covid Vaccines

News 18  

In the wake of pharmaceutical giant AstraZeneca admitting in a UK court that its Covid vaccine can cause blood clots in rare cases, a group of doctors on Thursday expressed deep concern over the safety of the Covishield vaccine manufactured by the Serum Institute of India. At a press conference, the doctors, under the banner of the Awaken India Movement, …

AstraZeneca withdraws Covishield pointing to low demand, but did rare side effects also play a role?
7 months, 2 weeks ago

AstraZeneca withdraws Covishield pointing to low demand, but did rare side effects also play a role?

The Hindu  

Published : May 09, 2024 13:21 IST - 3 MINS READ The pharmaceutical giant AstraZeneca has reportedly withdrawn its COVID-19 vaccine Vaxzevria, also known as Covishield, worldwide, citing commercial reasons for the decision. Vaxzevria saved millions of lives AstraZeneca, who developed the vaccine with Oxford University, said it was “incredibly proud of the role Vaxzevria played in ending the global …

AstraZeneca withdraws Covid vaccine worldwide after admitting it can cause rare blood clots
7 months, 2 weeks ago

AstraZeneca withdraws Covid vaccine worldwide after admitting it can cause rare blood clots

The Independent  

The best of Voices delivered to your inbox every week - from controversial columns to expert analysis Sign up for our free weekly Voices newsletter for expert opinion and columns Sign up to our free weekly Voices newsletter Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, …

AstraZeneca removes its Covid vaccine worldwide after rare and dangerous side effect linked to 80 deaths in Britain was admitted in court papers
7 months, 2 weeks ago

AstraZeneca removes its Covid vaccine worldwide after rare and dangerous side effect linked to 80 deaths in Britain was admitted in court papers

Daily Mail  

AstraZeneca is removing its Covid vaccine worldwide, months after the pharmaceutical giant admitted that it can cause a rare and dangerous side effect. The vaccine, once heralded as a 'triumph for British science', has come under intense scrutiny in recent months for a very rare side effect causing blood clots and low blood platelet counts. The AstraZeneca jab was the …

AstraZeneca reaffirms Covid vaccine safety amid rare side effect concerns
7 months, 3 weeks ago

AstraZeneca reaffirms Covid vaccine safety amid rare side effect concerns

India TV News  

In response to recent concerns regarding potential rare side effects associated with the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical company has underscored its unwavering commitment to patient safety while affirming the vaccine's overall safety profile. This comes in the wake of a recent admission by AstraZeneca, the pharmaceutical company, that its Covid vaccine Covishield and Vaxzevria "can, in very rare cases, …

UK-Based AstraZeneca Acknowledges Rare Health Risk Of Its Covid Vaccine In Court
7 months, 3 weeks ago

UK-Based AstraZeneca Acknowledges Rare Health Risk Of Its Covid Vaccine In Court

News 18  

UK-based AstraZeneca has acknowledged in court that its Covid vaccine can cause a rare blood clotting condition, British media reports said on Monday. The admission comes amid legal proceedings triggered by claims that the vaccine led to serious health complications, The Daily Mail reported. In a legal document submitted to a UK court in February, the Cambridge-based company conceded that …

Is AstraZeneca's Covid jab 'defective'? How firm that supplied 50million doses to the UK could face £90million lawsuit over rare blood clot side effect
1 year, 1 month ago

Is AstraZeneca's Covid jab 'defective'? How firm that supplied 50million doses to the UK could face £90million lawsuit over rare blood clot side effect

Daily Mail  

AstraZeneca said jab has 'acceptable safety profile' and regulators state that the benefits outweigh the risks of 'extremely rare potential side-effects' The jabs were dished out 50million times in the UK during the Covid pandemic The AstraZeneca Covid vaccine has been labelled 'defective' in a multi-million-pound lawsuit by patients who suffered a rare side-effect. IT engineer Jamie Scott suffered a …

Johnson & Johnson wants to shutter Leiden vaccine lab; cut jobs
1 year, 4 months ago

Johnson & Johnson wants to shutter Leiden vaccine lab; cut jobs

NL Times  

The Leiden pharmaceutical company Janssen intends to largely close its vaccine department because the American parent company Johnson & Johnson wants to focus more on other, new treatment methods. In 2021, then coronavirus minister Hugo de Jonge promoted the vaccine with the slogan “Dance with Janssen.” Many young people responded. But, in the following weeks, that led to many coronavirus …

Study confirms AstraZeneca jab’s higher risk of very rare clot
2 years, 1 month ago

Study confirms AstraZeneca jab’s higher risk of very rare clot

The Hindu  

AstraZeneca's Covid vaccine has been linked to a 30% higher risk of getting a very rare blood clotting condition compared to the Pfizer jab, a large international study said Thursday. Several countries have already altered their advice after previous research indicated that -- in a tiny number of cases -- thrombosis with thrombocytopenia syndrome can be a possible side effect …

AstraZeneca Covid Jab Linked to 30% Higher Risk of Very Rare Blood Clot: Study
2 years, 1 month ago

AstraZeneca Covid Jab Linked to 30% Higher Risk of Very Rare Blood Clot: Study

News 18  

AstraZeneca’s Covid vaccine has been linked to a 30-percent higher risk of getting a very rare blood clotting condition compared to the Pfizer jab, a large international study said Thursday. Several countries have already altered their advice after previous research indicated that — in a tiny number of cases — thrombosis with thrombocytopenia syndrome can be a possible side effect …

Africa's COVID vaccine production line in jeopardy
2 years, 7 months ago

Africa's COVID vaccine production line in jeopardy

The Hindu  

Trisha shakes her head when asked if she's vaccinated. 'A massive setback for Africa's plans' In the absence of orders or commitments, Aspen is considering the repurposing of two COVID-19 production lines for the manufacture of other products. "The continent would lose its only existing COVID vaccine manufacturing capacity," Nicolaou says. Africa's major public health body, the Africa Centers for …

FDA restricts Johnson & Johnson’s COVID-19 vaccine due to blood clot risk
2 years, 7 months ago

FDA restricts Johnson & Johnson’s COVID-19 vaccine due to blood clot risk

LA Times  

Vials of the Johnson & Johnson COVID-19 vaccine are seen at a pharmacy in 2021. U.S. regulators on Thursday strictly limited who can receive Johnson & Johnson’s COVID-19 vaccine due to the ongoing risk of rare but serious blood clots. FDA officials said in a statement that they decided to restrict J&J’s vaccine after taking another look at data on …

Third dose made available for people who received Janssen vaccine
2 years, 9 months ago

Third dose made available for people who received Janssen vaccine

Dutch News  

People who received the Janssen coronavirus vaccine can book a third jab from Wednesday if they need it to travel to other European countries, the health ministry has confirmed. The single-shot Janssen vaccine has caused problems for some travellers because countries such as Germany require people to have three doses before they qualify for a coronavirus access pass. ‘The health …

Very small blood clot risk after first AstraZeneca Covid shot, say UK studies
2 years, 10 months ago

Very small blood clot risk after first AstraZeneca Covid shot, say UK studies

India Today  

A large study into rare blood clots linked with AstraZeneca's Covid-19 vaccine found between just one and three cases per million, and only after the first dose, shedding fresh light on the side-effects from the shot. Read: BA.2 sub-variant of Omicron spreads faster, but not more severe, says WHO A study published in the PLOS Medicine journal on Tuesday looked …

WHO Europe warns of Covid rise in east, flags lagging vaccination rates
2 years, 10 months ago

WHO Europe warns of Covid rise in east, flags lagging vaccination rates

India Today  

The head of the World Health Organization’s Europe office said Tuesday that health officials are turning their attention to growing rates of COVID-19 infection in Eastern Europe, where six countries — including Russia and Ukraine — have seen a doubling in case counts over the last two weeks. Dr. Hans Kluge said the 53-country region, which stretches to former Soviet …

Vaccine skeptics slammed across Europe as Omicron rages
2 years, 11 months ago

Vaccine skeptics slammed across Europe as Omicron rages

Deccan Chronicle  

From Boris Johnson to Emmanuel Macron, Europe’s leaders are increasingly going after anti-vaxxers as the battle against the fast-spreading omicron variant deepens the region’s pandemic fatigue. French President Macron took the rhetoric to a new level this week when he said his government’s strategy was to “p--- off” those who have refused shots. In the U.K., Johnson accused anti-vaxxers of …

COVID: Study suggests AstraZeneca booster works against Omicron
3 years ago

COVID: Study suggests AstraZeneca booster works against Omicron

Al Jazeera  

Findings from the study, which has yet to be peer reviewed, match those from Pfizer-BioNTech and Moderna. AstraZeneca has said that a third dose of its COVID-19 vaccine “significantly” lifted antibody levels against the Omicron coronavirus variant, citing data from a new laboratory study. Boosters ‘limit Omicron spread’ Oxford’s researchers analysed blood samples taken from individuals infected with COVID-19; those …

Wrong to immediately give Covid passes to Janssen recipients: Drug maker
3 years, 1 month ago

Wrong to immediately give Covid passes to Janssen recipients: Drug maker

NL Times  

The developer of the Janssen vaccine "never thought" that people would assume that they were protected against Covid-19 immediately after vaccination. Because indeed, many people immediately received their vaccination certificate, which was, of course, clumsy," said Hanneke Schuitemaker, head of vaccine development at pharmaceutical company Janssen, on Thursday evening on talk show Jinek. Schuitemaker responded to the high wave of …

Mix-and-match vaccines highly effective against COVID-19: Lancet study
3 years, 2 months ago

Mix-and-match vaccines highly effective against COVID-19: Lancet study

Deccan Chronicle  

London: People who received a first dose of the Oxford-AstraZeneca COVID-19 vaccine followed by an mRNA vaccine shot had a lower risk of infection compared to those immunised with both doses of the AstraZeneca preventive, according to a nationwide study in Sweden. "However, our study shows a greater risk reduction for people who received an mRNA vaccine after having received …

People who got Janssen vaccine should get mRNA booster, study suggests
3 years, 2 months ago

People who got Janssen vaccine should get mRNA booster, study suggests

NL Times  

Americans vaccinated with the Janssen vaccine have a much stronger immune response to Covid-19 after a booster shot with an mRNA vaccine from Moderna or Pfizer/BioNTech than after a booster with Janssen. All 450 participants had a stronger immune response two weeks after the booster shot, but that effect was the greatest in people who originally received Janssen and then …

AstraZeneca Covid-19 vaccine shows 74% efficacy in large US trial
3 years, 2 months ago

AstraZeneca Covid-19 vaccine shows 74% efficacy in large US trial

India Today  

AstraZeneca Plc's Covid-19 vaccine demonstrated 74% efficacy at preventing symptomatic disease, a figure that increased to 83.5% in people aged 65 and older, according to long-awaited results of the company's US clinical trial published on Wednesday. Overall efficacy of 74% was lower than the interim 79% figure reported by the British drugmaker in March, a result AstraZeneca revised days later …

Two dose version of Johnson & Johnson shot 94% effective against Covid-19, study finds
3 years, 3 months ago

Two dose version of Johnson & Johnson shot 94% effective against Covid-19, study finds

CNN  

CNN — A two-dose version of Johnson & Johnson’s coronavirus vaccine provides 94% protection against symptomatic infection, the company said Tuesday – making a two-dose regimen of J&J’s Janssen vaccine comparable to a two-dose regimen of Moderna’s or Pfizer’s. “Our large real-world-evidence and Phase 3 studies confirm that the single-shot Johnson & Johnson vaccine provides strong and long-lasting protection against …

Got COVID-19 after two shots?: Four factors that increase the risk of vaccinated people getting infected – Firstpost
3 years, 3 months ago

Got COVID-19 after two shots?: Four factors that increase the risk of vaccinated people getting infected – Firstpost

Firstpost  

According to the COVID Symptom Study, the five most common symptoms of a breakthrough infection are a headache, a runny nose, sneezing, a sore throat and loss of smell Two weeks after your second COVID-19 vaccine dose, the protective effects of vaccination will be at their highest. But when facing the alpha variant, data from Public Health England suggests that …

EU to return millions of doses of J&J’s Covid-19 vaccine imported from Africa
3 years, 3 months ago

EU to return millions of doses of J&J’s Covid-19 vaccine imported from Africa

Live Mint  

The European Union will return to Africa millions of doses of Johnson & Johnson’s Covid-19 vaccine that it received from a plant in South Africa, following criticism by health activists that the bloc was taking away shots from a continent that has the lowest immunization rate in the world. Strive Masiyiwa, who heads the African Union’s Vaccine Acquisition Task Team, …

Risk of blood clotting after COVID-19 is higher than after getting vaccine, finds UK study
3 years, 3 months ago

Risk of blood clotting after COVID-19 is higher than after getting vaccine, finds UK study

Firstpost  

The study estimated that for 10 million people who received the AstraZeneca jab, there were seven additional cases, compared to 20 in people with Covid infection. Fears over rare cases of clotting conditions have prompted some countries to rule out or limit rollout of the Oxford-developed AstraZeneca jab, with the UK recommending that healthy people under 40 get alternative vaccines. …

Covid-19 vaccination rate among young people will play key role for rest of crisis: RIVM
3 years, 3 months ago

Covid-19 vaccination rate among young people will play key role for rest of crisis: RIVM

NL Times  

The vaccination rate among young people will play an important role in how the rest of the coronavirus crisis develops, director of the Center Infectious Disease Control at the RIVM Jaap van Dissel and RIVM chief modeler Jacco Wallinga told NOS. “There is a certain stability in the Netherlands but there is an underlying dynamic that will determine the developments …

Blood clot risk from COVID-19 is much higher than from vaccine, U.K. study shows
3 years, 3 months ago

Blood clot risk from COVID-19 is much higher than from vaccine, U.K. study shows

LA Times  

Boxes containing the Pfizer-BioNTech COVID-19 vaccine are prepared to be shipped at the Pfizer plant in Portage, Mich. COVID-19 patients face a much higher risk of developing blood clots than those vaccinated with the AstraZeneca or Pfizer shots, according to a large U.K. study. For every 10 million people who receive the first dose of AstraZeneca, about 66 more will …

Johnson & Johnson says talks with India on Covid vaccine Janssen still going on
3 years, 4 months ago

Johnson & Johnson says talks with India on Covid vaccine Janssen still going on

Hindustan Times  

Days after India's drugs regulator announced that Johnson & Johnson has pulled out its proposal seeking accelerated approval of its Covid-19 vaccine, the company said that the talks are still on. A health worker prepares a dose of Janssen Johnson & Johnson Covid-19 vaccine at Leopold Sedar Senghor stadium in Dakar, Senegal. Without giving any details, Central Drugs Standard Control …

Covid-19 vaccine holdouts face restrictions in Europe as Delta Variant spreads
3 years, 4 months ago

Covid-19 vaccine holdouts face restrictions in Europe as Delta Variant spreads

Live Mint  

European governments worried about the rapid spread of the Delta coronavirus variant are nudging, and in some cases pushing, people to get a shot by introducing restrictions to daily life for those without a Covid-19 vaccination. The governments have the dual objective of overcoming hesitancy among people who don’t have a hard-core ideological stance against vaccinations, while stemming the need …

FDA adds warning of rare reaction risk to J&J Covid vaccine
3 years, 5 months ago

FDA adds warning of rare reaction risk to J&J Covid vaccine

India TV News  

US regulators on Monday added a new warning to Johnson & Johnson's COVID-19 vaccine about links to a rare and potentially dangerous neurological reaction, but said it's not entirely clear the shot caused the problem. Health officials described the side effect as a “small possible risk" for those getting the shot.\ The action comes after the FDA and the Centers …

6.5 million fully vaccinated against Covid; Hospital total near 10-month low
3 years, 5 months ago

6.5 million fully vaccinated against Covid; Hospital total near 10-month low

NL Times  

Nearly 6.5 million people in the Netherlands have received either one shot of the Janssen Covid-19 vaccine, or two shots of any other Covid-19 vaccine. An estimated 4.4 million people have received only one shot of a two-dose vaccine, or about 30 percent of the adult population. The RIVM revised down the number of people who received a Covid-19 vaccination …

Dutch Health Min. defensive over letting newly-vaccinated people into events
3 years, 5 months ago

Dutch Health Min. defensive over letting newly-vaccinated people into events

NL Times  

Health Minister Hugo de Jonge defended the decision to allow people vaccinated against Covid-19 immediate access to nightclubs and events, even if the vaccine has not had enough time to reach maximum protection. The Health Council reiterated the advice to wait two weeks after the final Covid-19 vaccine dose for proper protection. De Jonge stated that he was aware of …

Nearly 6 million in the Netherlands now fully vaccinated against Covid-19
3 years, 5 months ago

Nearly 6 million in the Netherlands now fully vaccinated against Covid-19

NL Times  

New data about the Dutch Covid-19 vaccination program showed that 5,923,497 people in the country have either received one dose of the Janssen Vaccine, or two doses of any other vaccine in use in the Netherlands. It was not clear how many of them have also tested positive for the SARS-CoV-2 coronavirus infection in the past, which makes them “fully …

Another 175,000 Janssen Covid vaccine doses to be offered in the coming weeks
3 years, 5 months ago

Another 175,000 Janssen Covid vaccine doses to be offered in the coming weeks

NL Times  

An additional 175,000 doses of the Janssen Vaccine will be made available to the Netherlands residents in the coming weeks, the Health Ministry announced. The Janssen Vaccine was highly sought after by many people this week as it only requires one shot for maximum protection. It is still not clear how quickly Janssen Vaccine doses will be delivered to the …

Janssen Covid vaccines back in use today
3 years, 6 months ago

Janssen Covid vaccines back in use today

NL Times  

The first people who signed up to receive the Janssen Covid-19 vaccine were administered their shots on Friday. Unlike the other Covid-19 vaccines in use in the Netherlands, the Janssen Vaccine only requires one shot. Netherlands residents who already had an appointment for another vaccine, but preferred to get the Janssen jab, were also allowed to switch their appointments provided …

Phone lines overloaded as demand for the Janssen vaccine soars
3 years, 6 months ago

Phone lines overloaded as demand for the Janssen vaccine soars

Dutch News  

Hundreds of thousands of people tried to get in touch with a special regional health board phone line to make an appointment for the single dose Janssen vaccine on Wednesday. The phone line fielded over 4.4 million calls during the day, with one person telling DutchNews.nl it was ‘worse than trying to get a ticket for the Lowlands festival’. The …

78,000 appointments for Janssen vaccine made on first day
3 years, 6 months ago

78,000 appointments for Janssen vaccine made on first day

NL Times  

On the first day that appointments for Janssen vaccines were open to all adult Netherlands residents, 78 thousand people managed to get an appointment for a shot. A total of 222 thousand people made 5.3 million calls to health service GGD to try and get an appointment, Health Minister Hugo de Jonge said on Twitter. With Janssen vaccines opening to …

Janssen vaccine available from Wednesday, but supplies are limited
3 years, 6 months ago

Janssen vaccine available from Wednesday, but supplies are limited

Dutch News  

From Wednesday, people in the Netherlands who have not yet been vaccinated can make an appointment to have a single-dose Janssen shot before supplies run out. The Leiden-developed vaccine was removed from the Dutch vaccination programme because of very rare side effects, but health minister Hugo de Jonge has cleared its use by people who are aware of the possible …

Bookings for Janssen vaccine start at 10:00 a.m.
3 years, 6 months ago

Bookings for Janssen vaccine start at 10:00 a.m.

NL Times  

From Wednesday, Netherlands residents can make an appointment to get the Janssen vaccine against Covid-19. Rond 10:00 uur kan wie nog geen prik heeft gehad de keuze maken voor Janssen via: 📞 0800-1295 Er is beperkte voorraad beschikbaar. The biggest upside of the Janssen vaccine is that it requires only one dose, unlike the other approved vaccines that require two …

34% fully vaccinated against Covid-19; Hospital total sets 9-month low
3 years, 6 months ago

34% fully vaccinated against Covid-19; Hospital total sets 9-month low

NL Times  

Roughly 34 percent of adults in the Netherlands have received either the one-shot Janssen Covid-19 vaccine, or two shots of another vaccine approved in Europe. Another 3,760,156 were either partially vaccinated against the disease, or will eventually be considered fully vaccinated if they were recently infected with the coronavirus. A total of 1,432,818 jabs were given last calendar week, down …

Coronavirus vaccine advice on AstraZeneca has changed again — here's what it means for under-60s
3 years, 6 months ago

Coronavirus vaccine advice on AstraZeneca has changed again — here's what it means for under-60s

ABC  

The Pfizer vaccine is now the preferred coronavirus jab for Australians under 60, after medical experts re-assessed the risks posed by the AstraZeneca inoculation. But in the past week, seven out of 12 people in Australia who developed TTS after the AstraZeneca vaccine were in the 50-59 age group. "And so people over 60 should still be rolling out to …

Residents born in 2000 can also book their Covid-19 vaccine appointments
3 years, 6 months ago

Residents born in 2000 can also book their Covid-19 vaccine appointments

NL Times  

The 227 thousand people living in the Netherlands who were born in 2000 can make arrangements to get vaccinated against Covid-19, Health Minister Hugo de Jonge and the RIVM announced on Thursday. The mRNA vaccines usually require a booster shot weeks after the first dose was given to be considered fully protected against severe symptoms of the disease. Starting next …

People born in 1999 can register for a Covid-19 vaccine
3 years, 6 months ago

People born in 1999 can register for a Covid-19 vaccine

NL Times  

Health Minister Hugo de Jonge used his Twitter account to announce that all residents of the Netherlands born in 1999 can schedule their Covid-19 vaccine shots starting Thursday morning. Adult residents will be allowed to switch the appointment or schedule a new one to receive the Janssen Vaccine starting on Monday. Roughly 13 million Covid-19 vaccine doses have been administered …

How are blood clots associated with the AstraZeneca vaccine detected and treated?
3 years, 6 months ago

How are blood clots associated with the AstraZeneca vaccine detected and treated?

ABC  

Last week, a 52-year-old woman in New South Wales died of an extremely rare blood clot in her brain. Key points: Thrombosis with thrombocytopenia syndrome — also known as vaccine-induced prothrombotic immune thrombocytopenia — is an extremely rare side-effect of the AstraZeneca vaccine The blood clotting disorder can be detected as soon as symptoms appear with standard blood tests Treatment …

Stop AstraZeneca for Above 60 Also: EU Drug Regulator COVID Head
3 years, 6 months ago

Stop AstraZeneca for Above 60 Also: EU Drug Regulator COVID Head

The Quint  

Meanwhile, Italy has joined some other European countries in restricting the use of the vaccine to those above the age of 60. "In a pandemic context, our position was and is that the risk-benefit ratio remains favourable for all age groups," COVID-19 task force chief Marco Cavaleri told the Italian newspaper La Stampa. But when asked specifically if health authorities …

AstraZeneca shots should be halted for over-60s too: EMA official
3 years, 6 months ago

AstraZeneca shots should be halted for over-60s too: EMA official

India Today  

Countries should also avoid giving the Astrazeneca coronavirus vaccine to people over 60, the head of the EU drug regulator's Covid-19 task force was quoted on Sunday as saying, amid fears over rare blood clotting and as more vaccines become available. Asked whether health authorities should avoid giving the Astrazeneca vaccine to people aged over 60, Cavaleri said: "Yes, and …

The Netherlands is on the right track to overcoming coronavirus crisis: RIVM
3 years, 6 months ago

The Netherlands is on the right track to overcoming coronavirus crisis: RIVM

NL Times  

As Covid-19 vaccination figures rise and the summer is starting to get into full gear, coronavirus infection numbers have been steadily declining for the past weeks in the Netherlands. Director of Infectious Disease Control at the RIVM, Jaap van Dissel, and chief RIVM modeler, Jacco Wallinga said to NOS they are both optimistic that the Netherlands will continue making progress …

Italy halts AstraZeneca vaccine for under 60s
3 years, 6 months ago

Italy halts AstraZeneca vaccine for under 60s

India Today  

The Italian government said on Friday it was restricting the use of the AstraZeneca Covid-19 vaccine to people over the age of 60, after a teenager who had received the shot died from a rare form of blood clotting. People under the age of 60 who have received a first dose of AstraZeneca should be given a different vaccine for …

Covid-19 Vaccine: EU Advises Adding Condition to AstraZeneca Label
3 years, 6 months ago

Covid-19 Vaccine: EU Advises Adding Condition to AstraZeneca Label

News 18  

The European Medicines Agency says it's recommending that people who have had a rare blood vessel syndrome not be immunised with AstraZeneca's Covid-19 vaccine. In a statement on Friday, the EU drug regulator said it reviewed cases of six people who had capillary leak syndrome after they had received a shot of the AstraZeneca vaccine. EMA experts also concluded that …

AstraZeneca vaccine may be linked with small risk of low blood platelets: Study
3 years, 6 months ago

AstraZeneca vaccine may be linked with small risk of low blood platelets: Study

Hindustan Times  

The Oxford-AstraZeneca vaccine, known in India as Covishield, may be associated with a very small risk of developing a blood condition characterised by low platelet counts, according to a nationwide study in the UK. The study of 5.4 million people in Scotland, of whom 2.5 million had received their first vaccine dose, is the first analysis of ITP, clotting and …

Discover Related